|Hepatitis B infection| | | |
|Prophylactic antiviral therapy is strongly recommended over frequent monitoring alone for patients initiating rituximab who are hepatitis B core antibody positive (regardless of hepatitis B surface antigen status).|Very low|PICO 82|p. 459|